Adenomyosis - Symptoms, Causes, Treatment & Prevention

Symptoms

Symptoms can range from mild to severe and may overlap with other uterine disorders such as fibroids or endometriosis. Common manifestations include:

• Heavy or prolonged menstrual bleeding (menorrhagia): bleeding that lasts more than 7 days or requires frequent pad changes.
• Pyclic pelvic pain: dull, cramping pain that worsens during the first few days of the period.
• Chronic pelvic discomfort: a constant ache that may persist between periods.
• Dyspareunia (painful intercourse): especially deep penetration.
• Uterine enlargement: a feeling of fullness or pressure in the lower abdomen.
• Infertility or recurrent miscarriage: adenomyosis can affect implantation.
• Other nonspecific symptoms: fatigue, anemia from chronic blood loss, and irritability.

Some women experience only one symptom (commonly heavy bleeding), while others have a combination.

Causes and Risk Factors

The exact cause of adenomyosis remains uncertain, but several theories exist:

1. Invasion theory: Endometrial cells invade the myometrium through direct tissue injury, such as after uterine surgery.
2. De novo development: Stem‑cell‑like cells within the myometrium differentiate into endometrial tissue.
3. Hormonal influence: Estrogen stimulates growth of ectopic endometrial tissue; adenomyosis lesions often express high estrogen receptors.

Risk factors identified in the literature include:

• Age 35–50 years.
• Prior uterine surgery (e.g., Cesarean section, myomectomy, dilation & curettage).
• Multiparity (having given birth to several children).
• History of uterine fibroids.
• High estrogen exposure (early menarche, obesity, hormone‑replacement therapy).
• African‑American ethnicity appears to have a slightly higher prevalence, though data are limited.

Diagnosis

Diagnosing adenomyosis often requires a combination of clinical evaluation and imaging, because the definitive diagnosis historically required histopathology after hysterectomy.

1. Clinical assessment

• Detailed menstrual and pain history.
• Physical exam may reveal a diffusely enlarged, boggy uterus.

2. Imaging studies

• Transvaginal ultrasound (TVUS): First‑line, readily available. Findings suggestive of adenomyosis include a heterogeneous myometrium, myometrial cysts, thickened junctional zone (>12 mm), and enhanced vascularity. Sensitivity ~80 %, specificity ~70 %【2】.
• Magnetic resonance imaging (MRI): Gold standard non‑invasive test. T2‑weighted images show a thickened junctional zone, high‑intensity foci, and “shadowing” sign. Sensitivity up to 90 % and specificity >85 %【3】.
• 3‑D Ultrasound: Improves visualization of the junctional zone and is comparable to MRI in experienced hands.

3. Histopathology (rarely needed)

When a hysterectomy is performed for other reasons, the removed uterus is examined. Presence of endometrial glands and stroma within the myometrium confirms the diagnosis.

4. Laboratory tests

Blood tests are not diagnostic but may be ordered to assess anemia (CBC) or rule out other causes of abnormal bleeding.

Treatment Options

Management is individualized based on symptom severity, desire for future fertility, age, and comorbidities. Options range from medical therapy to minimally invasive procedures to definitive surgery.

1. Medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): First‑line for pain relief (e.g., ibuprofen 400–600 mg q6‑8h).
• Hormonal therapies:
  • Combined oral contraceptives – stabilize endometrial shedding.
  • Progestin‑only agents (e.g., levonorgestrel IUS, oral norethindrone) – reduce bleeding and pain.
  • Gonadotropin‑releasing hormone (GnRH) agonists (e.g., leuprolide) – induce a hypo‑estrogenic state, shrinking lesions; typically limited to 3–6 months due to bone loss risk.
  • GnRH antagonists (e.g., elagolix) – newer oral options with fewer side effects, approved for endometriosis and increasingly used off‑label for adenomyosis.
• Tranexamic acid: Reduces menstrual blood loss when taken during the first 5–7 days of the cycle.

2. Minimally invasive procedures

• Uterine artery embolization (UAE): Radiologic occlusion of uterine arteries decreases blood flow to adenomyotic tissue, leading to symptom improvement in 70–80 % of women. Fertility outcomes are variable.
• Laparoscopic or hysteroscopic adenomyomectomy: Surgical removal of focal adenomyosis while preserving the uterus; most effective for localized “adenomyoma” lesions.
• High‑intensity focused ultrasound (HIFU): MRI‑guided ablation of adenomyotic tissue; outpatient procedure with modest symptom relief.

3. Definitive surgery

When symptoms are severe and fertility is not a priority, a hysterectomy (removal of the uterus) offers a cure. Options include total abdominal, laparoscopic, or robotic‑assisted hysterectomy. Preservation of the ovaries is often recommended to avoid premature menopause unless there is an indication for oophorectomy.

4. Lifestyle and supportive measures

• Regular aerobic exercise can lessen pelvic pain.
• Iron‑rich diet or supplementation for anemia.
• Heat therapy (warm packs) during menstrual cramps.
• Stress‑reduction techniques (yoga, meditation) may lower perceived pain.

Living with Adenomyosis

While the condition can be chronic, many women learn to manage symptoms effectively.

• Bleeding diary: Track flow, pain scores, and treatment response to identify patterns.
• Plan ahead for heavy days: Keep extra sanitary products, schedule flexible work or school arrangements.
• Regular follow‑up: Annual visits with a gynecologist to reassess symptom control and adjust therapy.
• Fertility counseling: If pregnancy is desired, discuss timing of medical therapy (e.g., stopping GnRH agonists 2–3 months before conception) and consider assisted reproductive techniques.
• Support networks: Online forums, local support groups, or counseling can reduce isolation.

Prevention

Because the exact cause is unknown, specific primary‑prevention strategies are limited. However, certain measures may reduce risk or delay onset:

• Maintain a healthy weight to lower estrogen excess from adipose tissue.
• Avoid unnecessary uterine surgeries when possible; discuss alternatives with your surgeon.
• Use hormonal contraception judiciously; continuous‑use combined pills may lessen cyclic endometrial stimulation.
• Screen and treat endometriosis early, as co‑existence increases the likelihood of adenomyosis.

Complications

If left untreated or poorly managed, adenomyosis can lead to:

• Severe anemia: Chronic blood loss may cause iron‑deficiency anemia, fatigue, and reduced quality of life.
• Infertility or recurrent pregnancy loss: Distorted uterine architecture can impair implantation.
• Growth of the uterus: Marked uterine enlargement can cause urinary frequency or constipation.
• Pain chronicity: Persistent pelvic pain may develop central sensitization, making it harder to treat.
• Psychological impact: Depression, anxiety, and reduced sexual satisfaction are reported in up to 30 % of affected women【4】.

When to Seek Emergency Care

References

1. Mayo Clinic. Adenomyosis. Updated 2023. https://www.mayoclinic.org
2. American College of Obstetricians and Gynecologists. “Adenomyosis: Diagnosis and Management.” ACOG Committee Opinion No. 908, 2022.
3. F. K. L. Wang et al., “Magnetic Resonance Imaging of Adenomyosis: Correlation With Histopathologic Findings,” *Radiology*, vol. 297, no. 2, 2020, pp. 345‑354.
4. V. S. Mahajan & S. S. Alur, “Quality of Life in Women with Adenomyosis,” *Journal of Women's Health*, 2021;30(4): 473‑480.
5. U.S. National Institutes of Health. NIH Clinical Guidelines on Hormonal Therapies for Benign Gynecologic Conditions. 2022.
6. World Health Organization. “Global Prevalence of Gynecologic Disorders.” WHO Reproductive Health Series, 2021.